Compass Therapeutics
CMPX
#9468
Rank
A$0.18 B
Marketcap
A$1.04
Share price
1.43%
Change (1 day)
-86.21%
Change (1 year)

Earnings for Compass Therapeutics (CMPX)

Earnings in 2026 (TTM): -A$0.12 Billion

According to Compass Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.12 Billion a decrease over its 2024 earnings that were of -A$85.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Compass Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.12 Billion8.27%
2025 -A$0.12 Billion28.63%
2024 -A$85.56 Million12.43%
2023 -A$76.1 Million24.79%
2022 -A$60.98 Million-50.67%
2021 -A$0.13 Billion186.46%
2020 -A$43.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 92.56%๐Ÿ‡บ๐Ÿ‡ธ USA